Registered User? Login
Forgot Password?
Sign Up
loader image
New User? Sign Up
Forgot Password?
Login
loader image

    Flatiron Health is a healthtech company dedicated to improving cancer treatment and advancing research. We provide technology and services to support patient care and make every person’s story count. We partner with hundreds of cancer centers, 20+ top global developers of oncology therapeutics, and researchers and regulators around the world. Our vision is to build a world where technology and science close the gap between care and research.As the pioneer in real-world evidence for oncology, we provide technology and services to support patient care and make every person’s story count. We partner with hundreds of cancer centers, 20+ top global developers of oncology therapeutics, and researchers and regulators around the world. Our vision is to build a world where technology and science close the gap between care and research.

    WHO WE ARE

    Enhancing diversity in clinical trails - the time for action is now.

    For decades, many groups of individuals have been underrepresented in clinical trials on the basis of race, ethnicity, age, sex, gender and social determinants of health. This lack of representation significantly hampers our understanding of treatment responses in diverse populations, perpetuating cancer care inequities and resulting in poor outcomes among historically marginalized communities. Although enhancing diversity in clinical trials has long been a focus for sponsors, the FDA's 2022 guidance now mandates sponsors develop diversity action plans, ensuring therapies are tested in representative populations.

    Health equity is a key priority in oncology care and clinical trial research. Learn more about what we are doing in this space.

    Improving diversity in clinical trials by using real-world data to define eligibility criteria

    Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022

    Flatiron Health Leverages Expertise With Real-World Data to Examine Cancer Care Disparities

    Trial eligibility criteria and diversity among patients with advanced non small cell lung cancer

    Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data

    Evaluating External Validity of Oncology Biosimilar Safety Studies

    Stay connected

    CONTACT US